Pegsitacianine Informs Surgery in Peritoneal Carcinomatosis
Currently, cytoreductive surgery remains a pillar of modern treatment for peritoneal carcinomatosis.
Gut Microbiome Shows Potential as New Option for Patients With Colorectal Cancer
In an interview with Targeted Oncology, Patrick Wagner, MD, FACS, discussed the possibility of using the gut microbiome for patients with colorectal cancer, as well as his own research on the topic.